Cargando…
Nuclear GSK3β promotes tumorigenesis by phosphorylating KDM1A and inducing its deubiquitination by USP22
Emerging evidences have shown that GSK3β plays oncogenic roles in multiple tumor types; however, the underlying mechanisms remain largely unknown. Herein, we show that nuclear GSK3β is responsible for the accumulation of the histone demethylase KDM1A and critically regulates histone H3K4 methylation...
Autores principales: | Zhou, Aidong, Lin, Kangyu, Zhang, Sicong, Chen, Yaohui, Zhang, Nu, Xue, Jianfei, Wang, Zhongyong, Aldape, Kenneth D., Xie, Keping, Woodgett, James R., Huang, Suyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026327/ https://www.ncbi.nlm.nih.gov/pubmed/27501329 http://dx.doi.org/10.1038/ncb3396 |
Ejemplares similares
-
Tumour suppressor TRIM33 targets nuclear β-catenin degradation
por: Xue, Jianfei, et al.
Publicado: (2015) -
USP13 promotes deubiquitination of ZHX2 and tumorigenesis in kidney cancer
por: Xie, Haibiao, et al.
Publicado: (2022) -
USP17 Suppresses Tumorigenesis and Tumor Growth through Deubiquitinating AEP
por: Chen, Xi, et al.
Publicado: (2019) -
Critical role of lncEPAT in coupling dysregulated EGFR pathway and histone H2A deubiquitination during glioblastoma tumorigenesis
por: Li, Linlin, et al.
Publicado: (2022) -
Deubiquitination in prostate cancer progression: role of USP22
por: Nag, Nivedita, et al.
Publicado: (2020)